Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
NEW YORK (Reuters Health) - Women who have breast reconstruction after cancer surgery tend to be happier with the cosmetic results of silicone implants than with saline-filled ones, a study published Monday suggests.
NEW YORK (Reuters Health) - Women who take brisk walks regularly have a lower risk of developing breast cancer after menopause -- and it's never too late to start, new study findings suggest.
NEW YORK (Reuters Health) - Eating lots of carrots and cruciferous vegetables -- collard greens, cabbage, broccoli -- could reduce breast cancer risk, particularly an aggressive form common among African American women, suggests a large new study.
NEW YORK (Reuters Health) - More evidence suggests eating soy may pose a slight benefit to some women who have been diagnosed with breast cancer, but it's too early to recommend cancer survivors change their diets, some experts say.
CHICAGO (Reuters) - Women who took hormone replacement pills had more advanced breast cancers and were more likely to die from them than women who took a dummy pill, raising new concerns about the commonly prescribed drugs, U.S. researchers said on Tuesday.
MILAN (Reuters) - An established targeted therapy for bowel cancer may also help women with an aggressive form of breast cancer, a mid-stage clinical study revealed on Monday, opening up a potential new market for the medicine.
NEW YORK (Reuters Health) - Among women who survive early-stage breast cancer, some who make a habit of having a few drinks per week could face a greater risk of a recurrence than survivors who abstain, a new study suggests.
WASHINGTON, Sept 29 (Reuters) - In a study likely to add to the debate over when and how often to screen for breast cancer, Swedish researchers said on Wednesday that women aged 40-49 who got regular mammograms were 29 percent less likely to die of the disease.
ZURICH (Reuters) - European healthcare regulators are reviewing the benefits of Roche's top-selling Avastin drug in breast cancer in the light of fresh clinical data, casting more uncertainty over its prospects.
CHICAGO (Reuters) - Breast cancer rates among postmenopausal women in Canada dropped nearly 10 percent after news of a big study in 2002 that found taking hormone replacement therapy could increase breast cancer risk, researchers said on Thursday.